









Markets
/
Stocks
/
nasdaq-talk
/

Talkspace Inc

TALK

2.650USD

+0.110+4.33%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

445.05MMarket Cap

155.34P/E TTM



Talkspace Inc

2.650

+0.110+4.33%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

38 / 72

Overall Ranking

203 / 4721

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

4.800

Target Price

+88.98%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Talkspace, Inc. is a behavioral healthcare company, which offers access to a fully credentialed network of licensed therapists, psychologists and psychiatrists. Through its platform, the Company provides psychotherapy and psychiatry services to individuals, enterprises and health plans through both business-to-business (B2B) and business-to-customer (B2C) channels. In psychotherapy or talk therapy, members work with a licensed therapist or counsellor to treat specific mental health conditions, such as depression or anxiety, trauma and other human challenges, including by developing positive thinking and coping skills. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized, care from a prescriber who specializes in mental healthcare and prescription management. The Company offers its members a robust ecosystem for end-to-end behavioral healthcare.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 56.89% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD 1.15M.%!(EXTRA int=2)

Overvalued

The company’s latest PE is 156.34, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 104.56M shares, decreasing 27.36% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 8.97M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 8.35, which is higher than the Healthcare Providers & Services industry's average of 7.42. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 54.31M, representing a year-over-year increase of 17.92%, while its net profit experienced a year-over-year increase of 14.14%.

Score

Industry at a Glance

Previous score

8.35

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.43

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.15

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.76

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.41

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 1.20, which is lower than the Healthcare Providers & Services industry's average of 2.35. Its current P/E ratio is 149.85, which is -100.94% below the recent high of -1.41 and 114.07% above the recent low of -21.08.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 38/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.58. The average price target for Talkspace Inc is 5.00, with a high of 6.00 and a low of 3.50.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

4.800

Target Price

+88.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Talkspace Inc

TALK

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 6.64, which is lower than the Healthcare Providers & Services industry's average of 6.88. Sideways: Currently, the stock price is trading between the resistance level at 2.76 and the support level at 2.40, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.64

Change

0.54

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.014

Neutral

RSI(14)

54.161

Neutral

STOCH(KDJ)(9,3,3)

50.058

Buy

ATR(14)

0.088

High Vlolatility

CCI(14)

30.805

Neutral

Williams %R

28.889

Buy

TRIX(12,20)

-0.005

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

2.560

Buy

MA10

2.581

Buy

MA20

2.631

Buy

MA50

2.561

Buy

MA100

2.770

Sell

MA200

2.930

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 62.50%, representing a quarter-over-quarter increase of 2.40%. The largest institutional shareholder is The Vanguard, holding a total of 8.97M shares, representing 5.36% of shares outstanding, with 26.00% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Hudson Executive Capital LP

11.34M

Norwest Venture Partners

9.80M

-33.33%

The Vanguard Group, Inc.

Star Investors

7.65M

+6.54%

Qumra Capital

8.57M

BlackRock Institutional Trust Company, N.A.

7.74M

+0.81%

American Century Investment Management, Inc.

6.45M

-8.06%

DWS Investment Management Americas, Inc.

5.00M

+11.10%

State Street Global Advisors (US)

2.47M

+2.71%

AWM Investment Company, Inc.

3.97M

+3.93%

Braunstein (Douglas L)

3.91M

+0.15%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.65, which is lower than the Healthcare Providers & Services industry's average of 4.17. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.